Drug Type Small molecule drug |
Synonyms Crolibulin (USAN), EP2407, EPC-2407 + [2] |
Target |
Mechanism Tubulin inhibitors, Apoptosis inducers, Vascular disrupting agents (VDA) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17BrN4O3 |
InChIKeyJXONINOYTKKXQQ-CQSZACIVSA-N |
CAS Registry1000852-17-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaplastic Thyroid Carcinoma | Phase 2 | US | 26 Jan 2011 | |
Metastatic Solid Tumor | Phase 2 | US | 26 Jan 2011 | |
Lymphoma | Phase 2 | - | - | |
Lymphoma | Phase 2 | - | - | |
Advanced cancer | Phase 1 | US | 01 Dec 2006 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Dec 2006 |
Phase 1 | - | ulfyzhjfnc(hesaqjtuoi) = ccnrcjjqsq rrwlsukhjj (jdlvbepmhe ) View more | - | 20 May 2009 |